Form 4: HealthStream CEO Frist Reports Planned Share Transactions
Insider Transaction Report
HealthStream CEO Robert A. Frist Jr. reported planned future transactions under a Rule 10b5-1 plan, involving RSU vesting and tax-related share disposals.
Summary
- Robert A. Frist Jr., CEO and Chairman of HealthStream Inc., reported planned transactions under a Rule 10b5-1 trading plan, scheduled for March 30, 2026.
- The plan includes the acquisition of 4,038 shares of common stock upon the vesting of restricted share units.
- Concurrently, 984 shares of common stock are planned to be disposed of at a price of $21.25 per share to cover tax liabilities associated with the RSU vesting.
- Following these planned transactions, direct beneficial ownership of common stock will be 4,051,106 shares.
- Indirect beneficial ownership through various family trusts remains unchanged, totaling 1,069,997 shares.
- The filing also details future vesting schedules for several tranches of Restricted Share Units (RSUs) extending through March 2029.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation and tax management, with no significant positive or negative implications for the company's operational or financial health.
Positives
- The vesting of restricted share units (RSUs) indicates continued long-term incentive compensation for the CEO, aligning management interests with shareholder value.
- The transactions are pre-planned under a Rule 10b5-1 trading plan, which demonstrates a structured and transparent approach to managing executive compensation and tax obligations.
Future Outlook
The filing outlines future vesting schedules for Restricted Share Units (RSUs) for Robert A. Frist Jr., with tranches vesting annually through March 2029, contingent upon continued service.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those related to executive compensation like RSU vesting and subsequent tax-related sales, are common and provide insight into management's long-term commitment and compensation structure within the healthcare technology sector.
Comparison to Industry Standards
- The use of Restricted Share Units (RSUs) as a component of executive compensation, with multi-year vesting schedules, is a standard practice across many industries, including healthcare technology, to align executive incentives with long-term company performance.
- The disposal of shares to cover tax liabilities upon RSU vesting is also a routine and widely accepted practice for executives receiving equity compensation, consistent with practices observed at comparable companies like Cerner Corporation (now Oracle Health) or Allscripts Healthcare Solutions (now Veradigm).
Related Party Transactions
- Indirect beneficial ownership of common stock is held through various family trusts, including The Carolyn Marie Frist 2005 Vested Trust, The Eleanor Knox Frist 2005 Vested Trust, Louise Trust u/a/d 08-16-2007, Merriman Trust u/a/d 08-16-2007, Marie Trust u/a/d 08-16-2007, Knox Trust u/a/d 08-16-2007, and Bobby and Melissa Frist Children's 2012 GST-Exempt Trust.
Stakeholder Impact
- Shareholders: Minimal direct impact as these are routine compensation-related transactions, reflecting standard executive incentive structures.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Next Steps
- Future tranches of Restricted Share Units (RSUs) are scheduled to vest annually through March 2029, contingent upon continued service.
Key Dates
| Date | Description |
|---|---|
| 03/23/2023 | 15% of a tranche of Restricted Share Units (RSUs) vested. |
| 03/22/2024 | 20% of a tranche of Restricted Share Units (RSUs) vested. |
| 03/23/2024 | 20% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/20/2025 | 15% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/22/2025 | 30% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/23/2025 | 30% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/19/2026 | 15% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/20/2026 | 20% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/22/2026 | 30% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/23/2026 | 35% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/30/2026 | Planned transaction date for RSU vesting and tax-related share disposal. |
| 03/19/2027 | 20% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/20/2027 | 30% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/22/2027 | 35% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/19/2028 | 30% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/20/2028 | 35% of a tranche of Restricted Share Units (RSUs) vest. |
| 03/19/2029 | 35% of a tranche of Restricted Share Units (RSUs) vest. |
Recommendation
holdThis Form 4 reports routine insider transactions related to executive compensation (RSU vesting and tax withholding) under a pre-planned 10b5-1 trading plan. It does not provide new information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a catalyst for buying or selling.
Keywords
HSTM, HealthStream, Form 4, Insider Trading, Stock Transaction, RSU, Restricted Share Units, Robert A. Frist Jr., CEO, Director, 10% Owner, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.